Published on 13 Oct 2022 on Market Watch
Shares of Corbus Pharmaceuticals Holdings Inc. cratered 20.46% to $0.11 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.09% to 10,417.10 and Dow Jones Industrial Average falling 0.10% to 29,210.85. This was the stock's fourth consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed $1.00 below its 52-week high ($1.11), which the company achieved on November 16th.
The stock underperformed when compared to some of its competitors Wednesday, as Fate Therapeutics Inc. rose 1.91% to $21.33, Vanda Pharmaceuticals Inc. fell 1.02% to $9.71, and Viking Therapeutics Inc. rose 3.06% to $3.03. Trading volume (4.3 M) eclipsed its 50-day average volume of 1.2 M.